The Lenski Citrate Innovation
In Richard Lenski's long-term evolution experiment, one population of Escherichia coli evolved the ability to exploit citrate under aerobic experimental conditions, providing a detailed case study of evolutionary innovation.
The Investigative Question
What actually changed when E. coli evolved aerobic citrate utilization, and what does the experiment demonstrate?
What We Observe
For more than 30,000 generations, none of twelve experimental populations developed sustained aerobic citrate utilization. One population eventually acquired the trait and expanded into the newly available nutrient niche.
Scientific Background
Frozen samples allowed researchers to revisit earlier generations and investigate the history of the trait. Later genomic work identified changes involving altered expression of an existing citrate transporter and additional mutations that improved citrate utilization.
Why It Matters
The citrate experiment allows a proposed evolutionary innovation to be examined at the genetic level rather than discussed only in general terms.
What Is Known
The Cit+ phenotype evolved during the experiment. Genetic studies identified a tandem duplication that placed the existing citT citrate transporter under an aerobically active promoter, allowing the transporter to be expressed under conditions in which it had previously been silent. Additional mutations subsequently refined citrate utilization and reorganized metabolism.
What Is Proposed
Researchers interpret the case as an example of evolutionary innovation involving historical contingency, altered gene regulation, duplication, and subsequent refinement.
What Remains Uncertain
Researchers have identified important genetic changes that preceded, actualized, and refined the Cit+ innovation, but the complete contribution of all earlier mutations in the lineage has not been reconstructed. The significance of this experimentally observed metabolic innovation for much larger biological innovations requires separate evaluation.
Key Numbers
Cit+ appeared after more than 30,000 generations in one of twelve long-term experimental populations.
Design Relevance
The citrate case is important to Intelligent Design discussions because it provides an experimentally documented example of a new metabolic capability. The relevant question is what kind of genetic innovation occurred and what conclusions can reasonably be drawn from it.
Assessment
The Lenski experiment demonstrates that mutation and selection can produce a significant new metabolic phenotype. In this case, the initial Cit+ capability arose through a new regulatory arrangement involving an existing citrate transporter rather than through the origin of a new transporter gene. Earlier genetic changes affected the lineage in which the innovation arose, and later mutations refined the new capability. The case should therefore be evaluated for what it actually demonstrates rather than either dismissed as insignificant or treated as an explanation for biological innovations of every scale.